J Med Chem 62:27082719 Whittaker SJ, Demierre M-F, Kim EJ, Rook AH, Lerner A, Duvic M, Scarisbrick J, Reddy S, Robak T et al (2010) Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma
CagriSema's strategy of combining two proven mechanisms (amylin and GLP-1) in a single injection has produced strong Phase 3 results (20.4% weight loss), builds on the established semaglutide safety record, and is closest to market with an NDA filed
Peripheral patterns of calcitonin-gene-related peptide general somatic sensory innervation: cutaneous and deep terminations
USA 78 , 63726375 (1981)
The peptide caused skin irritation but otherwise appeared to be safe
There has been an explosion in popularity of unregulated injectable peptides in Australia, with social media users creating content about their supposed benefits and how to buy and use them